News

An ED Trial Examines Orgasm Intensity as Well as Firmness

An analysis in the November issue of The Journal of Sexual Medicine examines a question that erection trials do not always capture: how intense does orgasm feel? Researchers report improved orgasm-intensity scores with a sildenafil oral film, while stressing that this was an exploratory analysis rather than a prespecified main trial result.

Looking Beyond Erection Firmness

The study draws on a 12-week randomized trial at 17 U.S. centers. Investigators randomized 488 participants; 439 completed all visits. The researchers used the Orgasmometer, a self-reported scale from 0 to 10, to examine average orgasm intensity.

The analysis reports a 1.67-point advantage over placebo at week two, with improvement continuing through week 12. The journal published the paper online in October before its November issue. Because the researchers did not prespecify this analysis, the result needs confirmation rather than treatment as proof that the formulation cures orgasm disorders.

Three Sexual Functions That Need Separate Questions

Erection, ejaculation, and orgasm usually interact, but they describe different experiences. Erection concerns firmness, ejaculation concerns the release of semen, and orgasm concerns the experience of climax. A man can report a satisfactory erection and still struggle with delayed or absent orgasm. Another may experience orgasm despite a change in ejaculation.

EAU guidance treats delayed orgasm and anorgasmia as problems that need their own assessment. It asks clinicians to consider the onset, medicine use, health history, sensation, psychological factors, and the details of the sexual response. That broader history matters when a patient says that an ED treatment has helped one part of sex while another concern remains.

A Self-reported Outcome Answers a Patient-centered Question

An intensity scale records an experience that a blood test or erection-hardness measure cannot directly capture. That makes it useful, but it also requires care when interpreting averages. A group improvement does not mean every participant experienced the same change or that a particular score guarantees satisfying sex.

Researchers also need to distinguish a direct effect on orgasm from changes that follow more reliable erections, confidence, or successful sexual activity. This study cannot settle every possible explanation. Future trials can make orgasm outcomes part of the plan from the start and test whether the pattern holds in different patient groups.

The Medicine Still Targets Erection Physiology

MedlinePlus explains that sildenafil supports blood flow to the penis during sexual stimulation. It does not increase sexual desire. Its safety information includes a warning against use with nitrates and describes interactions and adverse effects that require discussion with a clinician.

A new formulation or an additional questionnaire finding does not remove those precautions. The study did not compare the film directly with every other sildenafil formulation, so it cannot establish superiority over ordinary tablets. A man should not switch products, combine treatments, or increase a dose solely to chase a higher orgasm-intensity score.

Other Causes Can Still Need Attention

NHS information describes several contributors to ejaculation problems, including certain medicines, alcohol, recreational drugs, psychological factors, and health conditions. Some antidepressants can delay ejaculation. Reviewing a suspected medicine effect requires the prescriber; abruptly stopping treatment can create other problems.

Tell the clinician whether the change happens during partnered sex, masturbation, or both. Describe whether you reach orgasm later than you want, cannot reach it, or reach it with reduced intensity. Those are more useful descriptions than treating every concern as a failure to get hard enough.

A Post-hoc Result Needs a New Test

An exploratory analysis can identify an outcome worth studying, but researchers choose the question after the original trial plan. A later study can define the orgasm measure in advance, state the main comparison, and enroll participants with the specific concern it aims to treat.

Until then, the result gives patients a reason to describe sexual quality in more detail. It does not establish a treatment for every cause of weak or absent orgasm. The useful next step involves matching the patient's complaint to an assessment, rather than assuming the same explanation for erection firmness, ejaculation, and the experience of climax.

What to Ask at a Sexual-health Appointment

Ask whether the assessment should address erection reliability and orgasm separately. Bring a list of medicines and a timeline of changes, particularly if the problem began after surgery, an illness, or a prescription change. Mention any pain, altered sensation, or difficulty with ejaculation rather than leaving it out because an ED medicine already helps firmness.

The new analysis gives clinicians another outcome to discuss. It does not replace an individual evaluation of a persistent orgasm concern. Our ED treatment page describes available approaches, and the consultation form lets you request an appointment to discuss the full pattern of symptoms.

Sources

Comments

Leave a comment